Impact BioMedical, Inc. Strategic Asset Allocation Index
Impact BioMedical, Inc. strategic asset allocation index. Impact BioMedical, Inc. (IBO) has a Strategic Asset Allocation Index of 0.2% as of March 2025. Strategic assets (PP&E of $16.00K plus long-term investments of $-) total $16.00K, measured against net assets of $6.81 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check IBO tangible net worth ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Impact BioMedical, Inc. (2021–2024)
Strategic asset allocation index of Impact BioMedical, Inc. from 2021 to 2024. This chart shows how Impact BioMedical, Inc.'s Strategic Asset Allocation Index has evolved across 4 annual periods from 2021 to 2024. As of March 2025, the index stands at 0.2%, representing strategic assets of $16.00K against net assets of $6.81 Million USD.
Impact BioMedical, Inc. Strategic Asset Allocation Index by Year (2021–2024)
Impact BioMedical, Inc. strategic asset allocation index by year from 2021 to 2024. The table below presents the year-by-year Strategic Asset Allocation Index for Impact BioMedical, Inc. from 2021 to 2024, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Impact BioMedical, Inc..
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.2% | $17.00K | $17.00K | $- | $7.24 Million | ▼ -0.8 pp |
| 2023 | 1.0% | $287.00K | $287.00K | $0.00 | $28.26 Million | ▼ -2.2 pp |
| 2022 | 3.2% | $1.06 Million | $276.00K | $782.00K | $32.67 Million | ▼ -160.4 pp |
| 2021 | 163.6% | $4.82 Million | $- | $4.82 Million | $2.94 Million | — |